Sleep Apnea Devices Market: Growth, Size, Share, and Trends

Market Growth Outlook Summary

The global sleep apnea devices market, valued at US$6.0 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, reaching US$6.5 billion in 2024 and an impressive US$9.3 billion by 2029. The market also observes lucrative growth opportunities with growing adoption of telemedicine, mHealth and artificial intelligence for treatment and diagnosis of sleep apnea along with expansion of leading players into emerging countries such as India, Australia, UAE and Saudi Arabia. There has been an increasing trend of health agencies expanding the reimbursement coverage of remote patient monitoring and other connected health services. On the other hand, products like compact PAP machines, wearable sleep monitors are gaining popularity in the sleep apnea devices market.

Sleep Apnea Devices Market Size, Dynamics & Ecosystem

To know about the assumptions considered for the study, Request for Free Sample Report

Sleep apnea devices Market Dynamics

DRIVER: Increased investments and funding for advancement of sleep apnea products

Increased investments and funding expenditure by leading manufacturers for innovations in sleep apnea products are driving significant innovations in the market, such as the development of more comfortable, efficient, and user-friendly CPAP devices and diagnostics. These rise of investments leads to improving research and development, resulting in innovative technologies which further improve patient compliance and therapeutic outcomes. Additionally, these funding supports led to expanded market reach and improved accessibility to advanced sleep apnea solutions across the globe.

RESTRAINT: Insufficient awareness of sleep apnea

Insufficient awareness of sleep apnea and its further health consequences to restraint the growth of sleep apnea devices market. It has been reported that several individuals remain undiagnosed and are unaware of sleep apnea as they fail to recognize the symptoms or understand the risks associated with the condition. This underdiagnosis of sleep apnea leads to less number of people seeking necessary medical intervention and utilizing the available therapeutic options, which is further limiting the market expansion.

OPPORTUNITY: Rising adoption of the cost-effective home sleep apnea tests

An increasing number of people are opting for the home treatments due to the huge out-of-pocket expenditure healthcare costs in hospital settings. The home healthcare market includes many devices, including sleep apnea diagnostic and therapeutic devices. These devices and services provide patients with cost-effective healthcare. Several next-generation sleep-sensing technologies are emerging as effective tools for home sleep apnea tests (HSATs), offering comfort and ease of access. Improving home sleep apnea testing and management is expected to generate more opportunities for growth in the sleep apnea devices market.

CHALLENGE: Lesser compliance rate associated with CPAP devices

CPAP comes with several disadvantages and a negative patient compliance record. Poor adherence to CPAP limits its clinical effectiveness, leading to a need for additional therapeutic options. CPAP devices are noisy, large, and have ill-fitting masks. In addition, sleep apnea patients at times feel discomfort due to the flow of the air during exhalation. To overcome these issues, device manufacturers are working towards developing CPAP devices that are smaller and quieter. Furthermore, in 2024, University of Cincinnati researchers announced development of a new CPAP devices called the VortexPAP providing better fit, airflow and sound.

Sleep Apnea Devices Market Segmentation & Geographical Spread

To know about the assumptions considered for the study, download the pdf brochure

PAP devices segment accounted for the largest share among therapeutic devices of the sleep apnea devices industry in 2023, by product.

The sleep apnea devices market is categorized into positive airway pressure (PAP) devices, facial interfaces (masks), accessories, oral appliances, and other therapeutic devices, based on the product. In 2023, the PAP devices segment emerged as the leading sector in the sleep apnea devices market. The large share of this segment can majorly be attributed to the continuous devices innovation to make it smaller quieter and more comfortable.

;The largest share in the sleep apnea devices industry in 2023 was held by the home care settings/individuals, by end user.

Categorized by its various end users, the sleep apnea devices market includes sleep laboratories, clinics, and hospitals and home care settings/individuals. As of 2023, the largest portion of the market was dominated by the home care settings/individuals segment. Sleep laboratories, clinics and hospitals segment to observe growth due to advancing infrastructure, and innovative diagnostic and therapy devices.

Asia Pacific observed the highest growth rate of the sleep apnea devices industry in 2023.

Categorized into six primary regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries, the sleep apnea devices market witnessed North America taking the forefront in 2023However, Asia Pacific region is expected to observe highest growth rate in the market as large patient pool influenced with comorbidities such as obesity and aging coupled with large population of undiagnosed sleep apnea patients indicate a massive potential for the Asia Pacific market. Countries in the region are also observing increase in sleep clinics over the last few years. On the other hand, leading players in sleep apnea market are adopting inorganic growth strategies to expand their presence in countries like India and Australia.

The major players in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare Limited (New Zealand). These players lead the market because of their extensive product portfolios and wide geographic presence.

Scope of the Sleep Apnea Devices Industry:

This report categorizes the sleep apnea devices market to forecast revenue and analyze trends in each of the following submarkets:

By Product

• Therapeutic Devices
  • PAP Devices
    • CPAP Devices
    • APAP Devices
    • BPAP Devices
  • Facial Interfaces
    • Masks
      • Full-face Masks
      • Nasal Pillow Masks
      • Nasal Masks
    • Cushions
  • Accessories
    • Humidifiers Accessories
    • Power Accessories
    • Transportation Accessories
    • Communication Accessories
    • Chin Restraints
    • Other Accessories
  • Oral Appliances
    • Mandibular Advancement Devices
    • Tongue-retaining Devices
    • Daytime-Nighttime Appliances
  • Other Therapeutic Devices
• Diagnostic Devices
  • PSG Devices
    • Abulatory PSG Devices
    • Clinical PSG Devices
  • Home Sleep Testing Devices
  • Oximeters
    • Fingertip Oximeters
    • Handheld Oximeters
    • Wrist-worn Oximeters
    • Tabletop Oximeters
  • Actigraphy Systsems
  • Sleep Screening Devices

By End User

• Sleep Laboratories, Clinics, and Hospitals
• Home Care Settings/ Individuals

By Age Group

• Below 40 Years
• 40-60 Years
• Above 60 Years

By Gender

• Male Patients
• Female Patients

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
    • Kingdom of Saudi Arabia
    • UAE
    • Other GCC Countries

Recent Developments of Sleep Apnea Devices Industry:

• In June 2024, ResMed (US) launched Airfit f40, an ultra-compact, full-face mask offering the comfort of smaller masks to improve sleep apnea therapy compliance.
• In April 2024, Fisher & Paykel Healthcare Limited (New Zealand) launched Autofit nasal and pillow masks to simplify the setup process in the US.
• In May 2023, Dynaflex (US) acquired Whole You, Inc. (US), a US sleep and respiratory care therapeutic segment leader. Whole You, Inc. has led the sleep apnea oral appliances market for the past decade.
• In November 2022, ResMed (US) opened its new 25,000-square-meter advanced manufacturing center in Tuas, Singapore, to serve as ResMed’s key manufacturing hub in the Asia Pacific.
• In October 2021, ResMed (US) acquired ectosense, a cloud-connected home sleep test (hst) leader, to expand its sleep apnea product offerings.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst